HALO
Halozyme Therapeutics, Inc. (HALO) Stock Statistics
Review Halozyme Therapeutics, Inc. (HALO) statistics with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- 1 month performance
- 6.21%
- 3 month performance
- 47.14%
- 6 month performance
- 84.26%
- 1 year performance
- 0%
- Sharpe ratio
- 1.37
- Volatility
- 37.26%
- Maximum drawdown
- -24.13%
Halozyme Therapeutics, Inc. (HALO) Stock Statistics research
These HALO statistics summarize available price performance and risk measures across several time horizons. Short and long windows can tell different stories, so the figures should be read together rather than treated as isolated signals.
Volatility, drawdown and risk-adjusted return describe historical behavior, not guaranteed future outcomes. Compare them with the company fundamentals and with appropriate sector peers before drawing a conclusion.